Archives for February 9, 2010

← 2010

PPD hit by higher number of cancellations in Q4

By Staff Reporter

US contract research organisation (CRO) PPD reported a “higher than anticipated” number of cancellations in Q4, bringing to a close 12 months that saw operating income fall 46 per cent to $192m.

MDRNA’s formulation stable after 12 months

By Nick Taylor

MDRNA’s liposomal drug delivery formulation, DiLA2, lost no potency when stored for 12 months in conditions ranging from -80ºC to 4ºC, helping to validate it for administration of UsiRNA.